<DOC>
	<DOCNO>NCT01600612</DOCNO>
	<brief_summary>Postpartum hemorrhage ( PPH ) lead cause maternal death worldwide , estimate mortality 140 000 per year . Uterine atony one important cause PPH . The traditional treatment use uterotonic agent . Oxytocin conventional drug prove effective . However , shortcoming short half life necessity intravenous administration . Misopristol , recently Carbetocin introduce treatment atonic PPP respond Oxytocin . Aim study evaluate effectiveness Carbetocin , Misopristol , Oxytocin treatment atonic PPH .</brief_summary>
	<brief_title>Oxytocin , Carbetocin Misopristol Treatment Postpartum Hemorrhage : A Multicentric Randomized Trial</brief_title>
	<detailed_description>The study conduct department Obstetrics Gynecology Sohag , Qena , Al Azhar , Assuit university hospital , Egypt . All patient atonic PPH deliver vaginally invite participate study . Patients delivered caesarean section , retain placenta , traumatic PPH , associate coagulopathy refuse participate study exclude . The patient randomly categorize 3 group ; first ( n = 100 ) receive 30 IU oxytocin intravenously ; second ( n = 100 ) receive 600 ug misopristol sublingually ; third ( n = 100 ) receive 100 ug Carbetocin IV . The randomization do use opaque seal envelops contain computer-generated code . The primary outcome study cessation bleed judge visual inspection blood loss trialist loss &lt; 300 mL blood first hour enrollment . The secondary outcome time control bleeding ( minute ) , amount blood loss till control bleeding ( mL ) , change hemoglobin level ( gm ) treatment , Changes hematocrite value ( % ) treatment , use additional uterotonic drug , rate complication ( % ) , necessity surgical intervention , cost medication . Written consent obtain participant approval local institutional ethical committee include .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>primary atonic postpartum hemorrhage vaginal delivery Patients deliver caesarean section Retained placenta Traumatic postpartum hemorrhage Associated coagulopathy Chronic medical illness ( hepatic , renal disease ) Refusal participate study .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>postpartum hemorrhage , oxytocin , carbetocin , misopristol</keyword>
</DOC>